MedTrace Logo

A Case-control Study Comparing Glycaemic Control in Pancreatic Cancer Patients vs Healthy Matched Individuals.

NCT05583890 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 29

Last updated 2025-06-04

No results posted yet for this study

Summary

The aim of this study is to continuously monitor blood glucose concentrations for a 7-day period in pancreatic cancer patients whilst undergoing their typical daily routines and to compare this to age matched healthy individuals. The investigators plan to carry out the study on a small subset of patients, up to 30 with pancreatic cancer (15 not undergoing chemotherapy and 15 undergoing chemotherapy) and 15 healthy individuals.

Conditions

Interventions

DEVICE

Continuous glucose monitors

Participants will wear continuous glucose monitors for a 7 day period.

DEVICE

Activity tracker

Participants will wear the activity tracker for a 7 day period.

BEHAVIORAL

Food Diary

Participants will complete a food diary of everything they eat for 7 days.

BEHAVIORAL

Questionnaires

Participants will complete FACT-Hep, DiPcare-Q and health inequality related questions.

Sponsors & Collaborators

  • East Lancashire Hospitals NHS Trust

    collaborator OTHER

  • Lancaster University

    lead OTHER

Principal Investigators

  • Christopher J Gaffney · Lancaster University

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-08-25
Primary Completion
2024-08-21
Completion
2024-08-28

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05583890 on ClinicalTrials.gov